tiprankstipranks
BioNeutra Global Corp (TSE:BGA)
TSXV:BGA
Canadian Market

BioNeutra Global (BGA) Stock Price & Analysis

111 Followers

BGA Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week Range<C$0.01 - C$0.16
Previous CloseC$0.05
Volume1.00K
Average Volume (3M)9.99K
Market Cap
C$2.46M
Enterprise ValueC$8.78M
Total Cash (Recent Filing)C$791.77K
Total Debt (Recent Filing)C$7.11M
Price to Earnings (P/E)
Beta-1.71
Aug 22, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding46,448,787
10 Day Avg. Volume1,100
30 Day Avg. Volume9,986
Standard Deviation0.73
R-Squared0.01
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)-0.47
Price to Sales (P/S)1.44
Price to Cash Flow (P/CF)2.70
P/FCF Ratio1.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

4.95%0.00%0.00%95.05%
4.95%
Insiders
0.00% Other Institutional Investors
95.05% Public Companies and
Individual Investors

BGA FAQ

What was BioNeutra Global Corp’s price range in the past 12 months?
BioNeutra Global Corp lowest stock price was <C$0.01 and its highest was C$0.16 in the past 12 months.
    What is BioNeutra Global Corp’s market cap?
    Currently, no data Available
    When is BioNeutra Global Corp’s upcoming earnings report date?
    BioNeutra Global Corp’s upcoming earnings report date is Aug 22, 2024 which is in 34 days.
      How were BioNeutra Global Corp’s earnings last quarter?
      Currently, no data Available
      Is BioNeutra Global Corp overvalued?
      According to Wall Street analysts BioNeutra Global Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does BioNeutra Global Corp pay dividends?
        BioNeutra Global Corp does not currently pay dividends.
        What is BioNeutra Global Corp’s EPS estimate?
        BioNeutra Global Corp’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does BioNeutra Global Corp have?
        BioNeutra Global Corp has 46,448,788 shares outstanding.
          What happened to BioNeutra Global Corp’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of BioNeutra Global Corp?
          Currently, no hedge funds are holding shares in TSE:BGA
          ---

          BioNeutra Global Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Positive
          20 days / 200 days
          Momentum
          51.42%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -10.91%
          Trailing 12-Months

          Company Description

          BioNeutra Global Corp

          BioNeutra Global Corp is a Canada based company engaged in research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. The company's product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both the powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. Majority of the revenue is derived from the United States.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          GLG Life Tech
          BC Bud Corporation
          Naturally Splendid
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis